Type 2 diabetes trials recruiting in Colorado

All Type 2 diabetes trials nationally

Cities in Colorado

Recruiting trials in Colorado

• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
  NCT07667803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Arvada
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
  NCT07662044 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Englewood
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
  NCT07664553 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora
• A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
  NCT06112418 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · Colorado: Aurora, Denver
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
  NCT07564414 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora
• A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
  NCT06739122 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · Colorado: Denver
• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
  NCT07282600 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora
• Breaking up Sedentary Time to Improve Glucose Control in a Population at Risk for Developing Type 2 Diabetes
  NCT05041491 · Phase: Early Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · Colorado: Aurora
• Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes
  NCT05543083 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 17 Years · Sex: Female · Colorado: Aurora, Fort Collins
• DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
  NCT06525259 · Phase: Not specified · Ages: 8 Years to 15 Years · Sex: All (male and female) · Colorado: Aurora
• DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes
  NCT06983054 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Colorado: Denver
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora, Golden
• Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
  NCT07579702 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 75 Years · Sex: All (male and female) · Colorado: Aurora
• Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
  NCT07521475 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Colorado: Denver
• GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
  NCT07228117 · Phase: Not applicable (e.g. observational or device study) · Ages: 7 Years to 85 Years · Sex: All (male and female) · Colorado: Aurora
• Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
  NCT06964087 · Phase: Phase 2 · Ages: 18 Years to 50 Years · Sex: All (male and female) · Colorado: Aurora
• Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
  NCT07216391 · Phase: Phase 2 · Ages: 4 Years to 34 Years · Sex: All (male and female) · Colorado: Aurora
• Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
  NCT07011147 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 89 Years · Sex: All (male and female) · Colorado: Aurora
• Project Dulce for Arab Americans With Type 2 Diabetes
  NCT05580536 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Denver
• Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
  NCT05008276 · Phase: Not specified · Ages: 8 Years to 14 Years · Sex: All (male and female) · Colorado: Aurora
• Registry for Stage 2 Type 1 Diabetes
  NCT06481904 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Colorado: Aurora
• Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
  NCT04791371 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 55 Years · Sex: All (male and female) · Colorado: Aurora
• SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes
  NCT07409714 · Phase: Early Phase 1 · Ages: 14 Years to 24 Years · Sex: All (male and female) · Colorado: Aurora
• Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification
  NCT05766735 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 80 Years · Sex: All (male and female) · Colorado: Aurora